4CPS-064 Quality of life study: galcanezumab in the treatment of migraine
Autor: | EM Barreiro Fernandez, E Rios-Sanchez, CM Dominguez-Santana, C Moreno-Ramos, MD Gil-Sierra |
---|---|
Rok vydání: | 2022 |
Zdroj: | Section 4: Clinical pharmacy services. |
DOI: | 10.1136/ejhpharm-2022-eahp.103 |
Databáze: | OpenAIRE |
Externí odkaz: |